As I understand it, the only plan to go to market with an oral form of Nadilol is for smoking cessation. All other indications will await an inhaled device. The mechanicals, the responsibility of 3M, should be just about finished. According to the time table there should be trials in inhaled Nadilol by mid next year. This is the real target.
AGM (31 - 0), page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 9749314 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6055724 | 26 |
View Market Depth
| Last trade - 10.04am 11/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |
Day chart unavailable